Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news



MEP Harkin on EU health claims:“It is very difficult to know where to go from here”

1 commentBy Shane Starling , 22-Mar-2012
Last updated on 29-Mar-2012 at 12:29 GMT2012-03-29T12:29:06Z

MEP Harkin on EU health claims:“It is very difficult to know where to go from here”

Irish MEP Marian Harkin said the European nutrition industry must look forward after a European Parliamentary committee yesterday rejected a bid to overturn a controversial, 222-strong health claims list.

“This Regulation will have serious consequences for small manufacturers of health food products in particular those who do not have the resources to fund Randomised Control Trials in the healthy population to back-up their claims,” Harkin said.

“Only the larger companies will have the resources to provide the type of evidence required by the Commission and this will have a significant effect on smaller manufacturers in particular.”

While Harkin acknowledged, "It is very difficult to know where to go from here," she said a pending report on the regulation from the European Ombudsman offered some hope amid the blow of the rejected veto.

“I wish the news was better on this and while the effects will not be immediate, none the less we know they are coming down the track and even at this late stage we have to see what options are available to us,” she said.

“It is worth noting that there is a complaint with the European Ombudsman and I will be very interested to see his substantive response. While he has no power to order the Commission to change the Regulation a positive response from him would strengthen our hand.”

“Genuine health claims”

If the full European Parliament (EP) does not block the regulation by April 27, the nutrition and health claims regulation (NHCR), article 13 list is likely to become law by the end of May. Six months after that, products bearing prohibited claims can be stripped from shelves across the 27 member states of the EU.

The motion to veto the list in the EP Public Health and Food Safety Committee (ENVI) failed by 15 votes – with 22 in favour of the veto, 37 against, with original objector, the Czech Socialist MEP Pavel Poc, abstaining.

Europe’s biggest food group, FoodDrinkEurope, along with the European Consumers Organisation (BEUC) welcomed the passing of the list as a moment when healthy food claim-making moved up a gear in Europe, giving more surety to consumers in a more unified market.

“The vote will stop consumers from being misled by unsubstantiated, exaggerated or untruthful claims about foodstuffs,” said Monique Goyens, director-general of BEUC.

“Only genuine health claims will be allowed to remain on the market.”

But other groups are concerned about a regulation that to date has condemned about 2000 claims including the likes of soy, probiotics and lutein.

“Poorly conceived”

Alliance for Natural Health executive and scientific director, Dr Robert Verkerk PhD, pointed to the level of opposition and said the fight against the regulation would go on.

“The push from Big Food, headed by FoodDrinkEurope, was just too strong,” he said. “But the fact that nearly 40% of the committee voted in favour of a veto reflects the concerns that many MEPs have over the Regulation.”

ANH, he said, would, ”persist in doing whatever we can to ensure the best possible outcome for one of the most poorly conceived pieces of European food law ever bestowed on the people of Europe.”
Typical lines of support were expressed by German MEP Dagmar Roth-Behrendt of the Progressive Alliance of Socialists and Democrats (S&D), who said: “The list we have is a good list as these health claims are justifiable.”

Looking forward, Dr Verkerk added: “Our main focus now needs to be on the rejected claims list, EFSA’s methods of scientific assessment, especially as they relate to botanicals, and implementation strategies of individual member states.”


Of some celebrated rejections, Harkin noted: “Everybody knows that prunes help keep you regular but the E.U. Commission is not yet convinced. Cranberry juice is widely used for helping in the treatment of urinary infections, yet it got the thumbs-down. Many many people use Glucosamine to assist with joint health and mobility, it also got the thumbs down as did magnesium which can help to prevent cramps.”

1 comment (Comments are now closed)

It's a positive, not a negative list !

The key legal element of the Claims Regulation is still misunderstood by many. The Community Register's essential legal instrument regulating 13.1 health claims is a POSITIVE LIST. A negative list with "prohibited" claims is redundant and disproportionate, because the Reguluation prohibits ALL health claims not included in the List. The fact that we're in a derogation period doesn't change this. It's only in the context of the Commission's administration of the derogation that some claims - pending and botanical - that were not placed on this - first - 13.1 List escape the general prohibition laid down in the Regulation.

Report abuse

Posted by Bert Schwitters
23 March 2012 | 12h422012-03-23T12:42:02Z

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars